‘Psyched’: DC Includes Psychedelics Measure On Ballot, GreenStar Buys Eleusian, MindMed Wraps Clinical Trial

District of Columbia To Include Psychedelics Decriminalization Measure on November Ballot

The District of Columbia will likely become the nation’s second jurisdiction to include a psychedelics decriminalization measure in November.

Oregon made a similar announcement last week, and will include psilocybin decriminalization on its ballot. In the case of DC, the ballot will also include ayahuasca and ibogaine, among others.

According to Decriminalize Nature DC, the activist organization behind the proposal, Initiative 81 would “make entheogens among the lowest law enforcement priorities for the Metropolitan Police Department.”

The initiative has gathered and certified enough signatures and the Board of Elections will formally announce its inclusion on August 5, Marijuana Moment reported.

The Lundquist Institute Receives $1.75M Donation to Research Psilocybin Treatment

The Lundquist Institute for Biomedical Innovation in Torrance, California, has accepted a $1.75 million anonymous donation meant to research psilocybin-assisted psychotherapy for terminally ill patients.

The grant will be used to fund a multi-site clinical trial that will evaluate the safety and efficacy of psilocybin in patients with severe psychological disorders associated with a terminal disease.

The trials will be conducted at the Harbor-UCLA Medical Center, as well as in other leading medical schools across …

Full story available on Benzinga.com

More 'Psyched': DC Includes Psychedelics Measure On Ballot, GreenStar Buys Eleusian, MindMed Wraps Clinical Trial